Literature DB >> 32391423

Axin2+ endometrial stem cells: the source of endometrial regeneration and cancer.

Shafiq M Syed1, Pradeep S Tanwar1.   

Abstract

Menstruation is one of the basic but poorly understood life processes in primates during which females shed inner uterine lining every month only to be completely regenerated back within a week. The definitive evidence for the existence and/or identity of stem cells responsible for this process has remained elusive for more than six decades now. Recently, we reported Axin2, a classical Wnt reporter gene, as a marker for endometrial stem cells that also serve as the cells of origin for endometrial cancer.
© 2020 Taylor & Francis Group, LLC.

Entities:  

Keywords:  Axin2; Endometrial stem cells; Wnt signaling; cancer; regeneration

Year:  2020        PMID： 32391423      PMCID： PMC7199746          DOI： 10.1080/23723556.2020.1729681

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN： 2372-3556


  8 in total

1.  Uteri of women with endometrial carcinoma contain a histopathological spectrum of monoclonal putative precancers, some with microsatellite instability.

Authors:  A S Jovanovic; K A Boynton; G L Mutter
Journal:  Cancer Res       Date:  1996-04-15       Impact factor: 12.701

Review 2.  Endometrial regeneration and endometrial stem/progenitor cells.

Authors:  Caroline E Gargett; Hong P T Nguyen; Louie Ye
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

3.  Mesenchymal-to-epithelial transition contributes to endometrial regeneration following natural and artificial decidualization.

Authors:  Amanda L Patterson; Ling Zhang; Nelson A Arango; Jose Teixeira; James K Pru
Journal:  Stem Cells Dev       Date:  2013-01-29       Impact factor: 3.272

4.  Endometrial Axin2+ Cells Drive Epithelial Homeostasis, Regeneration, and Cancer following Oncogenic Transformation.

Authors:  Shafiq M Syed; Manish Kumar; Arnab Ghosh; Florence Tomasetig; Ayesha Ali; Renee M Whan; Dariusz Alterman; Pradeep S Tanwar
Journal:  Cell Stem Cell       Date:  2019-12-26       Impact factor: 24.633

5.  Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman's syndrome and endometrial atrophy: a pilot cohort study.

Authors:  Xavier Santamaria; Sergio Cabanillas; Irene Cervelló; Cristina Arbona; Francisco Raga; Jaime Ferro; Julio Palmero; Jose Remohí; Antonio Pellicer; Carlos Simón
Journal:  Hum Reprod       Date:  2016-03-22       Impact factor: 6.918

6.  Stromal-to-epithelial transition during postpartum endometrial regeneration.

Authors:  Cheng-Chiu Huang; Grant D Orvis; Ying Wang; Richard R Behringer
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

7.  Systemic administration of bone marrow-derived cells leads to better uterine engraftment than use of uterine-derived cells or local injection.

Authors:  Ying Liu; Reshef Tal; Nicola Pluchino; Ramanaiah Mamillapalli; Hugh S Taylor
Journal:  J Cell Mol Med       Date:  2017-08-07       Impact factor: 5.310

Review 8.  Endometrial stem/progenitor cells: the first 10 years.

Authors:  Caroline E Gargett; Kjiana E Schwab; James A Deane
Journal:  Hum Reprod Update       Date:  2015-11-09       Impact factor: 15.610
  8 in total
  2 in total

Review 1.  Wnt/β-catenin signaling in cancers and targeted therapies.

Authors:  Fanyuan Yu; Changhao Yu; Feifei Li; Yanqin Zuo; Yitian Wang; Lin Yao; Chenzhou Wu; Chenglin Wang; Ling Ye
Journal:  Signal Transduct Target Ther       Date:  2021-08-30

2.  Additional evidence to support OCT-4 positive VSELs and EnSCs as the elusive tissue-resident stem/progenitor cells in adult mice uterus.

Authors:  Pushpa Singh; Siddhanath Metkari; Deepa Bhartiya
Journal:  Stem Cell Res Ther       Date:  2022-02-05       Impact factor: 6.832
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.